Buscar
Mostrando ítems 1-10 de 138
Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?
(Wolters Kluwer Health, 2015)
When prostate needle biopsies are involved discontinuously by tumor, no consensus remains on the optimal method of tumor quantification. We investigated whether discontinuous biopsy involvement usually results from a large ...
Prostate biopsy and radical prostatectomy Gleason score correlation in heterogenous tumors: proposal for a composite Gleason score
(Wolters Kluwer Health, 2015)
When prostate biopsy cores are separately identified in multiple containers, current recommendations are to grade each specimen individually. For treatment algorithms, the highest Gleason score (HGS) is typically used as ...
Role of minimally invasive surgery (MIS) in different sexual development (DSD)
(Elsevier Science Inc., 2021-08)
Differences/disorders of sex development (DSD) are a heterogeneous group of congenital conditions in which the development of chromosomal, gonadal, or anatomical sex is atypical. Patients usually present during the newborn ...
Evaluation of a biopsy technique of the epiphyseal plate radius of mules with angular deformity of surgical type : case studyEvaluación de una técnica de biopsia de la placa epifisaria del radio de mulares con deformidad angular de tipo quirúrgica : estudio de caso
(Universidad de Antioquia, Facultad de Ciencias AgrariasCENTAUROMedellín, Colombia, 2017)
Immunophenotypic Shifts in Primary Cutaneous gammadelta T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens
(Wolters Kluwer Health, 2017)
Primary cutaneous gammadelta T-cell lymphoma (PCGD TCL), an aggressive type of lymphoma, accounts for approximately 1% of all primary cutaneous lymphomas. We have occasionally observed changes in T-cell antigen expression ...
Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: A case report
(Frontiers Media S.A., 2015-04)
We have developed a therapeutic vaccine consisting of a mixture of lethally-irradiated allogeneic cutaneous melanoma cell lines with BCG and GM-CSF as adjuvants. The CSF-470 vaccine is currently being assayed in a Phase ...